June 24, 2021

June 24, 2021

Disappointing Response to COVID-19 Vaccination in Another CLL (Chronic Lymphocytic Leukemia) Patient

Here is one more article in our series on the those who are vaccinated and still vulnerable such as this one from Dr. Lindsay Ryan. In this case the patient, Michele Nadeem-Baker, like Dr. Ryan, is acutely aware of her ongoing risk and through her efforts to make her

June 24, 2021

COVID-19 Protection for CLL Patients is Possible, But it May Not Be Available

COVID-19 Protection for CLL Patients Is Possible, But It May Not Be Available. CLL Society is sharing a series of articles addressing the issue of CLL patients being vaccinated, but still unprotected, and sometimes unaware of their continued risk.

June 24, 2021

ASH 2020: Dr. Davids Discusses Duvelisib and Venetoclax, an All-Oral Time-Limited Treatment for Chronic Lymphocytic Leukemia (CLL)

The team at Dana-Farber Cancer Institute is testing whether the combination of duvelisib (Copiktra™) and venetoclax (Venclexta®) will lead to deep remissions that would allow for oral only therapy of one year duration. Learn more about this ongoing Phase I/II clinical trial.

June 24, 2021

ASH 2020: Dr. Furman Discusses Minimal Residual Disease-Driven Captivate and Murano Studies in Chronic Lymphocytic Leukemia (CLL)

The treatment landscape for those of us with CLL/SLL has changed dramatically in the past decade or less. We see decreasing reliance on chemoimmunotherapies that were the only option in the past. We have seen a move from sequential use of targeted therapies to control our CLL to combinations

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

June 24, 2021

Disappointing Response to COVID-19 Vaccination in Another CLL (Chronic Lymphocytic Leukemia) Patient

COVID-19 Protection for CLL Patients is Possible, But it May Not Be Available

ASH 2020: Dr. Davids Discusses Duvelisib and Venetoclax, an All-Oral Time-Limited Treatment for Chronic Lymphocytic Leukemia (CLL)

ASH 2020: Dr. Furman Discusses Minimal Residual Disease-Driven Captivate and Murano Studies in Chronic Lymphocytic Leukemia (CLL)

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT